InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Lawley Lori D, 首席财务官. Officer active across 2 companies, notably LUMOS PHARMA, INC.. Cumulatively, 11 disclosures have been published. History available since 1 August 2021. The latest transaction was disclosed on 1 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Lawley Lori D is Directeur Financier at Lumos Pharma, INC. on XNAS. She has 11 filings, and the sampled recent filings cover the period from 2021-08-03 to 2024-12-13, with transaction nature indicated as tax withholding.